Press release
Complicated Urinary Tract Infections Treatment Market Size in the 7MM was valued ~USD 1,600 Million which is expected to increase by 2034
Unlock key insights into the Complicated Urinary Tract Infection Market! Download DelveInsight's comprehensive report to explore market trends, pipeline analysis, and emerging therapies @ Complicated Urinary Tract Infection Market Size [https://www.delveinsight.com/sample-request/complicated-urinary-tract-infections-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Key Takeaways from the Complicated Urinary Tract Infection Market Report
* In April 2025, Rempex announced a study is to assess the safety and tolerability of meropenem-vaborbactam administered by intravenous (IV) infusion in children 3 months and above to less than 12 years with complicated urinary tract infections (cUTI), including acute pyelonephritis (AP).
* In April 2025, Menarini Group announced clinical trial is to assess the pharmacokinetic (PK) and safety and tolerability of Vaborem ( fixed combination of meropenem and vaborbactam) in the paediatric population aged from 3 months to < 18 years with complicated urinary tract infection (cUTI) including acute pyelonephritis (AP) in need of hospitalisation and intravenous (IV) antibiotic administration.
* In April 2025, Shionogi announced a study is to understand the pharmacokinetics (PK) of single and multiple doses of cefiderocol in children from birth to less than 3 months of age with suspected or confirmed aerobic Gram-negative bacterial infections.
* In the 7MM, nearly 1,000,000 cUTI incident cases progressed from uUTI in the year 2023, which is expected to increase during the forecast period (2024-2034).
* In the US, maximum number of cUTI cases were observed for the age group of 65-84 years, followed by =85 years.
* Among the EU4 and the UK, Germany recorded the highest number of diagnosed-incident cases of cUTI with approximately 26% cases in 2023, which is estimated to rise by 2034, at a CAGR of 0.6%.
* Japan accounted for around 800,000 cases of cUTI in 2023 caused due to Uropathogenic Escherichia coli, followed by 100,000 cases caused by Klebsiella pneumonia.
* The leading Complicated Urinary Tract Infection Companies such as Merck Sharp & Dohme, AbbVie, Pfizer, Allecra Therapeutics, Wockhardt, Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, GlaxoSmithKline, Locus Biosciences, Forest Laboratories, Allecra, Xiangbei Welman Pharmaceutical, Bayer, Mepha Ltd., Pinnacle Pharmaceuticals, Inc., Bionorica SE, and others
* Promising Complicated Urinary Tract Infection Therapies such as RECARBRIO (imipenem, cilastatin, and relebactam), AVYCAZ (ceftazidime/avibactam), enmetazobactam, zidebactam (WCK-5222), Tebipenem Pivoxil Hydrobromide (SPR994), Cefepime/zidebactam (WCK-5222), Cefepime/taniborbactam, Gepotidacin, LBP-EC01, Ceftaroline fosamil and NXL104 (q8h), cefepime/AAI101 combination, Piperacillin Sodium and Sulbactam Sodium, Cipro XR (Ciprofloxacin, BAYQ3939), Nitrofurantoin, PP4001, Canephron Registered N , and others.
Stay ahead in the competitive landscape of the Complicated Urinary Tract Infection Market. Access DelveInsight's in-depth market analysis and strategic insights today! Click here for more @ Complicated Urinary Tract Infection Treatment Market Size [https://www.delveinsight.com/sample-request/complicated-urinary-tract-infections-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Complicated Urinary Tract Infection Epidemiology Segmentation in the 7MM
* Complicated Urinary Tract Infections Diagnosed Incident cases
* Complicated Urinary Tract Infections Diagnosed Incident cases progressed
* Complicated Urinary Tract Infections Age-specific cases
* Pathogen-specific cases
* Total treated cases of Complicated Urinary Tract Infections
Download the report to understand which factors are driving Complicated Urinary Tract Infection epidemiology trends @ Complicated Urinary Tract Infection Prevalence [https://www.delveinsight.com/sample-request/complicated-urinary-tract-infections-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Complicated Urinary Tract Infections Marketed Therapies
* RECARBRIO (imipenem, cilastatin, and relebactam): Merck Sharp & Dohme
RECARBRIO is a combination of imipenem, a penem antibacterial; cilastatin, a renal dehydropeptidase inhibitor; and relebactam, a beta-lactamase inhibitor. It is indicated in patients 18 years of age and older for the treatment of cUTIs, including pyelonephritis caused by the following susceptible Gram-negative microorganisms: Enterobacter cloacae, Escherichia coli, Klebsiella aerogenes, Klebsiella pneumoniae, and Pseudomonas aeruginosa in patients who have limited or no alternative treatment options. In July 2019, the US FDA approved RECARBRIO (imipenem, cilastatin, and relebactam), an antibacterial drug product to treat adults with cUTI.
* AVYCAZ (ceftazidime/avibactam): AbbVie/Pfizer
AVYCAZ is a combination of ceftazidime, a cephalosporin, and avibactam, a beta-lactamase inhibitor, indicated for the treatment of cUTI, including pyelonephritis, in adult and pediatric patients 3 months and older caused by the following susceptible Gram-negative microorganisms. In November 2020, the EMA approved ZAVICEFTA (ceftazidime-avibactam) for the treatment of children aged 3 months and older with cUTIs.
Complicated Urinary Tract Infections Emerging Therapies
* Cefepime/enmetazobactam: Allecra Therapeutics
The combination of enmetazobactam with the fourth-generation cephalosporine, cefepime, is intended to provide a novel therapeutic option addressing this serious threat. Allecra Therapeutics is currently developing the novel Ss-lactamase inhibitor enmetazobactam, which has potent activity against Class A serine Ss-lactamases, specifically ESBL. Enmetazobactam is a derivative of tazobactam, but from a molecule comparison, there are significant differences to expect higher potency. In June 2023, Allecra Therapeutics submitted an NDA to the US FDA for EXBLIFEP, an antibiotic combination of cefepime/enmetazobactam targeting cUTIs.
* Cefepime/zidebactam (WCK-5222): Wockhardt
WCK-5222 (cefepime/zidebactam) is a novel Ss-lactam enhancer mechanism-of-action based antibiotic designed to address the myriad of Ss-lactamases that keep evolving and rendering even newer Ss-lactam-based antibiotics ineffective. Zidebactam is a first-in-class Ss-lactam enhancer with potent inhibition of penicillin-binding protein (PBP) 2 of all the clinically relevant Gram-negative organisms, including Pseudomonas aeruginosa, Acinetobacter baumannii, and Enterobacterales. It is currently being investigated in a Phase III, randomized, double-blind, multicenter, comparative study to determine the efficacy and safety of cefepime-zidebactam vs meropenem in the treatment of complicated urinary tract infection or acute pyelonephritis in adults. The study is expected to be completed by April 2024.
Discover the future of Complicated Urinary Tract Infection Treatments with DelveInsight's latest market report. Get expert insights and forecasts-download now! @ Complicated Urinary Tract Infection Market Drivers and Barriers [https://www.delveinsight.com/sample-request/complicated-urinary-tract-infections-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Complicated Urinary Tract Infections Companies
Merck Sharp & Dohme, AbbVie, Pfizer, Allecra Therapeutics, Wockhardt, Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, GlaxoSmithKline, Locus Biosciences, Forest Laboratories, Allecra, Xiangbei Welman Pharmaceutical, Bayer, Mepha Ltd., Pinnacle Pharmaceuticals, Inc., Bionorica SE, and others.
Complicated Urinary Tract Infections Market Outlook
One of the most common bacterial illnesses is a Urinary Tract Infection. UTIs can manifest clinically in various ways, from relatively benign, uncomplicated infections to complicated UTIs (cUTIs), pyelonephritis, and severe urosepsis. Antimicrobial therapy is the first choice of therapy for patients diagnosed with cUTI. ZERBAXA (ceftolozane/tazobactam), designed by Cubist pharmaceuticals, was the first approved drug for adults diagnosed with cUTI in 2014. Later the drug was acquired by Merck & Dohme.
Explore the dynamics of the Complicated Urinary Tract Infection Market with DelveInsight. From market size to emerging drugs-find it all in our latest report. Read now! @ Complicated Urinary Tract Infection Ongoing Clinical Trials Analysis [https://www.delveinsight.com/sample-request/complicated-urinary-tract-infections-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=ypr]
Scope of the Complicated Urinary Tract Infection Market Report
* Coverage- 7MM
* Study Period- 2020-2034
* Complicated Urinary Tract Infection Companies- Merck Sharp & Dohme, AbbVie, Pfizer, Allecra Therapeutics, Wockhardt, Spero Therapeutics, Wockhardt, Venatorx Pharmaceuticals, GlaxoSmithKline, Locus Biosciences, Forest Laboratories, Allecra, Xiangbei Welman Pharmaceutical, Bayer, Mepha Ltd., Pinnacle Pharmaceuticals, Inc., Bionorica SE, and others.
* Complicated Urinary Tract Infection Therapies- RECARBRIO (imipenem, cilastatin, and relebactam), AVYCAZ (ceftazidime/avibactam), enmetazobactam, zidebactam (WCK-5222), Tebipenem Pivoxil Hydrobromide (SPR994), Cefepime/zidebactam (WCK-5222), Cefepime/taniborbactam, Gepotidacin, LBP-EC01, Ceftaroline fosamil and NXL104 (q8h), cefepime/AAI101 combination, Piperacillin Sodium and Sulbactam Sodium, Cipro XR (Ciprofloxacin, BAYQ3939), Nitrofurantoin, PP4001, Canephron Registered N , and others.
* Complicated Urinary Tract Infection Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
* Complicated Urinary Tract Infection Unmet Needs, KOL's views, Analyst's views, Complicated Urinary Tract Infection Market Access and Reimbursement
Table of Content
1. Key Insights
2. Report Introduction
3. Complicated Urinary Tract Infection Market Overview at a Glance
4. Executive Summary of Complicated Urinary Tract Infection
5. Key Events
6. Complicated Urinary Tract Infections Market Disease Background and Overview
7. Complicated Urinary Tract Infections Treatment and Management
8. Methodology
9. Complicated Urinary Tract Infections Epidemiology and Patient Population
10. Complicated Urinary Tract Infections Patient Journey
11. Complicated Urinary Tract Infections Marketed Drugs
12. Complicated Urinary Tract Infections Emerging Therapies
13. Complicated Urinary Tract Infection Market- Seven Major Market Analysis
14. Complicated Urinary Tract Infections KOL Views
15. Complicated Urinary Tract Infections Unmet Needs
16. Complicated Urinary Tract Infections SWOT Analysis
17. Complicated Urinary Tract Infections Market Access and Reimbursement
18. The United States
19. EU4 and the UK
20. Japan
21. Appendix
22. DelveInsight Capabilities
23. Disclaimer
24. About DelveInsight
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=complicated-urinary-tract-infections-treatment-market-size-in-the-7mm-was-valued-usd-1600-million-which-is-expected-to-increase-by-2034]
Phone: 09650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/report-store/complicated-urinary-tract-infections-market
Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Complicated Urinary Tract Infections Treatment Market Size in the 7MM was valued ~USD 1,600 Million which is expected to increase by 2034 here
News-ID: 3980547 • Views: …
More Releases from ABNewswire
Fawcett Publications Launches Innovative Programs to Help Writers Publish and Pr …
Diverse Stories, One Community
At Fawcett Publications [https://fawcettpublications.com?utm_source=chatgpt.com], we transform your writing into a published work of art. Whether you're crafting a screenplay, memoir, business book, or children's story, our seasoned team ensures your vision becomes reality through expert writing, editing, publishing, marketing, and design services.
Publishing Made Easy
Our packages include everything from formatting, cover design, and proofreading to hardcover publishing, editorial assessments, promotional book videos, and distribution across print and digital…
MediterraneanPlan.com Launches Comprehensive Resource Spotlighting Mediterranean …
Mediterranean Plan the leading authority on healthy Mediterranean living, today unveiled an enhanced suite of resources to support individuals seeking Mediterranean diet, mediterranean diet plans [https://www.google.com/url?q=https://www.google.com/url?q%3Dhttps://blog.mediterraneanplan.com/what-is-the-mediterranean-diet-plan/?utm_source%253Dchatgpt.com%26amp;sa%3DD%26amp;source%3Deditors%26amp;ust%3D1756747121659237%26amp;usg%3DAOvVaw2Dnd1HgtuKZr5SmV5vK7a_&sa=D&source=docs&ust=1756747121672029&usg=AOvVaw3UEHPibfdNKrQ9ILLCpqKd], mediterranean diet benefits and a deeper understanding of the mediterranean diet recipes [https://www.google.com/url?q=https://www.google.com/url?q%3Dhttps://blog.mediterraneanplan.com/%26amp;sa%3DD%26amp;source%3Deditors%26amp;ust%3D1756747121659690%26amp;usg%3DAOvVaw2GOwrEHMV1NdUON9CfPoLA&sa=D&source=docs&ust=1756747121672241&usg=AOvVaw2neY_GG8MbrE5lz61HvGgo].
With fresh content added throughout August 2025-covering categories such as cooking tips, portion control, superfoods, and cholesterol reduction-MediterraneanPlan.com offers readers tools to embrace this science-backed, sustainable lifestyle.
Empowering Mediterranean Diet Adoption with Practical…
HOZO Design Launches the M-Cube 02 Laser Level Premium Combo: The Ultimate Solut …
Image: https://www.abnewswire.com/upload/2025/09/9412983740d69cf1fa6d5d148e70ec38.jpg
HOZO Design, an industry leader in innovative measurement technology, has announced the release of the M-Cube 02 Laser Level Premium Combo, a cutting-edge tool that combines advanced measurement, alignment, and positioning into one powerful solution. Designed for professionals in construction, design, and engineering, this versatile laser level redefines precision with its modular technology and intuitive functionality.
Measure, Align, and Position with Confidence
The M-Cube 02 [https://hozodesign.com/products/m-cube-02-laser-level-premium-combo] Premium Combo includes the M-Cube…
From DIY Home Improvement to 3D Modeling - HOZO Design Redefines Precision with …
Image: https://www.abnewswire.com/upload/2025/09/bc4a735f9fe3ba57d6792a460ee412d0.jpg
HOZO Design [https://hozodesign.com/] continues to reshape the world of creative tools with its award-winning portfolio of smart measuring devices that empower professionals, makers, and enthusiasts worldwide. From studios and job sites to living rooms filled with fresh ideas, HOZO stands at the intersection of design and technology, creating tools that make DIY home improvement, product design, and 3D modeling smarter, simpler, and more enjoyable.
Empowering Creativity, One Precise Measurement at…
More Releases for Urinary
Emerging Urinary Incontinence Market Trend 2025-2034: Pioneering Patient Care Wi …
How Is the Urinary Incontinence Market Projected to Grow, and What Is Its Market Size?
The market for urinary incontinence has witnessed significant expansion in the recent past. It is forecasted to progress from a valuation of $12.52 billion in 2024 to an estimated worth of $13.37 billion in 2025, predicting a Compound Annual Growth Rate (CAGR) of 6.8%. Factors that contributed to this growth during the historical period include a…
Urinary Drainage Bags Market Is Driven By Urinary Drainage Bags In Various Indus …
The Urinary Drainage Bags Market has experienced substantial growth in recent years, driven by a combination of factors, including the increasing elderly population, a higher prevalence of urinary incontinence, and a growing emphasis on patient care and comfort. Urinary drainage bags are essential medical devices used for the collection and management of urine in individuals with various medical conditions, such as those recovering from surgery, dealing with urinary retention, or…
Urinary Catheters Market - Urinary Catheters: Innovations Transforming Comfort a …
Newark, New Castle, USA: The "Urinary Catheters Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Urinary Catheters Market: https://www.growthplusreports.com/report/urinary-catheters-market/8720
This latest report researches the industry structure, sales, revenue,…
Urinary Stents Market - Unleash the Power of Urinary Stents: Elevate Your Urolog …
Newark, New Castle, USA: The "Urinary Stents Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Urinary Stents Market: https://www.growthplusreports.com/report/urinary-stents-market/8681
This latest report researches the industry structure, sales, revenue,…
Urinary Catheters Market: The ins and Outs of Urinary Catheters with Region Wise …
Allied Market Research recently said Urinary catheters are a medical device used to drain urine from the bladder when a patient is unable to do so on their own. They are commonly used in hospitals and long-term care facilities, as well as for individuals with certain medical conditions. Urinary catheters come in a variety of types, including indwelling catheters, which remain in the bladder for an extended period of time,…
Urinary Incontinence Market: New research activities show links between urinary …
The prevalence of urinary incontinence has affected a majority of population and the possibility of this condition increases with age. Majority of old adults and women have been facing the issue and availing treatments to improve quality of lives. Research activities found the connection between urinary incontinence and other health conditions such as mental health and falls. After conducting different research activities, new findings have emerged. Researchers suggested doctors to…
